NCT07179419 Evaluation of the Long-term Therapeutic Effect of High-Intensity Focused Ultrasound (HIFU) Treatment in Patients With Rectal Endometriosis
| NCT ID | NCT07179419 |
| Status | Recruiting |
| Phase | — |
| Sponsor | EDAP TMS S.A. |
| Condition | Endometriosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 140 participants |
| Start Date | 2021-10-10 |
| Primary Completion | 2029-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 140 participants in total. It began in 2021-10-10 with a primary completion date of 2029-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Evaluate the long-term effects of HIFU treatment for rectal endometriosis.
Eligibility Criteria
Inclusion Criteria: * Patients who have been treated with HIFU for rectal endometriosis included in study HIFU/F/13.12, study HIFU/F/20.01 (ENDO HIFU R1) or study HIFU/F/21.12 (ENDO HIFU R2) * Agreeing to participate in the study * Patients with internet access so that they can complete the questionnaires electronically. Exclusion Criteria: * Patients deprived of their liberty following a judicial or administrative decision, * Patients under guardianship or conservatorship.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07179419 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Endometriosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07179419 currently recruiting?
Yes, NCT07179419 is actively recruiting participants. Contact the research team at affaires-cliniques@edap-tms.com for enrollment information.
Where is the NCT07179419 trial being conducted?
This trial is being conducted at Lyon, France.
Who is sponsoring the NCT07179419 clinical trial?
NCT07179419 is sponsored by EDAP TMS S.A.. The trial plans to enroll 140 participants.